Glycine reduces platelet aggregation

Area of Science:

• Pharmacology
• Hematology
• Neuroscience

Background:

• Glycine-gated chloride channels are present in various immune cells, including macrophages and neutrophils.
• Glycine binding to its receptor causes chloride influx, leading to membrane hyperpolarization and preventing calcium influx.
• Platelet aggregation is a calcium-dependent process crucial for hemostasis.

Purpose of the Study:

• To investigate the hypothesis that glycine inhibits platelet aggregation.
• To determine the role of glycine receptors in this inhibitory effect.
• To assess the effect of dietary glycine on bleeding time and platelet aggregation.

Main Methods:

• Rats were fed diets supplemented with glycine or valine for five days.
• Bleeding time and platelet aggregation induced by ADP and collagen were measured.
• Glycine was added in vitro to assess its direct effect on platelet aggregation, with and without strychnine (a glycine receptor antagonist).
• Western blotting was used to detect glycine receptors in rat and human platelets.

Main Results:

• Dietary glycine significantly increased bleeding time twofold compared to controls.
• Platelet aggregation induced by ADP or collagen was reduced by over 50% in rats fed glycine.
• In vitro glycine addition dose-dependently inhibited rat platelet aggregation.
• Strychnine abolished the inhibitory effect of glycine in vitro, indicating a role for glycine receptors.
• Glycine also inhibited human platelet aggregation, and glycine receptors were detected in both rat and human platelets.

Conclusions:

• Glycine effectively prevents platelet aggregation in a dose-dependent manner.
• This effect is mediated through glycine receptors present on platelets.
• Glycine holds potential for therapeutic applications in conditions involving excessive platelet aggregation.